Related Experiment Video

Updated: May 25, 2026

Pulse Wave Velocity Testing in the Baltimore Longitudinal Study of Aging
06:08

Pulse Wave Velocity Testing in the Baltimore Longitudinal Study of Aging

Published on: February 7, 2014

Increased arterial stiffness assessed by pulse wave velocity in Behçet's disease and its association with the lipid

C A M Caldas1, E F Borba, L A Bortolotto

  • 1Rheumatology Division, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.

Journal of the European Academy of Dermatology and Venereology : JEADV
|February 15, 2012
PubMed

Insights

Behçet

Area of Science:

  • Vascular Biology
  • Rheumatology
  • Cardiovascular Medicine

Background:

  • Behçet's Disease (BD) is a systemic inflammatory condition.
  • Vascular involvement is a significant complication in BD.
  • Traditional cardiovascular risk factors may not fully explain vascular damage in BD.

Purpose of the Study:

  • To assess arterial stiffness and structure in BD patients without traditional cardiovascular risk factors.
  • To compare carotid-femoral pulse wave velocity (PWV) and carotid ultrasound parameters between BD patients and healthy controls.
  • To investigate the relationship between disease characteristics and vascular properties in BD.

Main Methods:

  • Carotid-femoral pulse wave velocity (PWV) and carotid ultrasound were performed on 23 BD patients and age/sex-matched healthy controls.
  • BD patients were stratified by systemic and vascular involvement.
  • Multivariate regression analysis was used to identify factors influencing PWV.

Main Results:

  • BD patients exhibited significantly higher PWV compared to controls (8.48 ± 1.14 vs. 7.53 ± 1.40 m/s, P = 0.017).
  • Systemic involvement in BD correlated with higher PWV.
  • Triglycerides were identified as a key factor associated with increased PWV in BD patients.

Conclusions:

  • Pulse wave velocity (PWV) is a more sensitive indicator of vascular damage in Behçet's Disease than carotid ultrasound.
  • The disease itself contributes to vascular alterations, independent of traditional risk factors.
  • Strict management of lipoproteins and other risk factors is crucial in BD patients.
Abstract

More Related Videos

Measuring the Carotid to Femoral Pulse Wave Velocity (Cf-PWV) to Evaluate Arterial Stiffness05:51

Measuring the Carotid to Femoral Pulse Wave Velocity (Cf-PWV) to Evaluate Arterial Stiffness

Published on: May 3, 2018

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Pulse01:16

Pulse

When the heart pumps blood out, arterial elastic fibers play a crucial role in sustaining a high-pressure gradient. They expand to accommodate the received blood and then recoil - a process known as the pulse that can be either manually palpated or electronically quantified. Despite a reduction in its effect with increased distance from the heart, elements of the pulse's systolic and diastolic components persist, observable even at the arteriole level.
The pulse serves as a clinical indicator...